Data investigation

How to Verify an Online GLP-1 Pharmacy: Six Public Checks

Every check starts with the name of the dispensing pharmacy: the state board license database, FDA's 503B register and FDA's warning letters are all free, public, and take about ten minutes.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed
10 min read·9 citations

Part of Checking a seller before you buy

Every useful check starts from one piece of information: the name of the pharmacy that will fill your order. With it you can search a state board license database, FDA's register of outsourcing facilities and FDA's warning letters in about ten minutes, all of them free and public. Without it there is nothing to check, and a seller that will not give you the name has told you what you most needed to know.

This page is about the seller, not about your treatment. Nothing here is a reason to change, delay or stop a medication you have been prescribed. If a check turns up something that worries you, the call is to your prescriber and to the pharmacy, in that order.

Find the pharmacy's name first

Most GLP-1 you can buy online arrives through three separate parties wearing one brand. There is the brand on the website, the corporate entity that operates it, and the pharmacy that compounds and ships the vial. They are frequently three different names, and only the third one holds a license anyone can look up.

FDA's June 8, 2026 warning letter to Maximus Health, Inc. is a plain illustration. The letter is addressed to a company in Santa Monica, California, doing business as Maximus, which runs its website under yet another name.[5] Among the corrective steps FDA asked for was “identifying the entities that produce the compounded drug products offered on your website”. If the federal regulator has to ask a seller who makes the drug, a customer reading the homepage will not find out.

Three names, and what each one lets you verify
What it isWhere you see itWhat you can check
The brandThe website, the ads, the appNothing regulatory. A brand is a trademark, not a license.
The operating entityTerms of service, privacy policy, the footer, the charge on your cardState corporate filings; whether one operator runs several brands you thought were competitors.
The dispensing pharmacyOrder confirmation, shipping notice, the vial label, sometimes only the FAQState board of pharmacy license; FDA's 503B register if it claims to be one; FDA warning letters.

Look in the terms of service and the privacy policy before the marketing pages. Those documents are written by lawyers who need the entity named correctly, and they routinely disclose a pharmacy partner that the homepage does not. The shipping confirmation and the vial itself are the other two reliable places. We record the pharmacy for every seller we can trace in our pharmacy register, and we say so when we could not trace one. Some terms still stop short. TrimRx’s describe an independent, state-licensed compounding pharmacy without naming it, so you would need to ask before ordering. LongevityFix MD’s terms name no operating company at all, and they announce a mandatory arbitration provision in Section XXI but end after Section IV. While you are in the terms, read every clause that mentions a pharmacy: four sellers in our register ask you to waive your choice of one.

Sellers differ widely on this first step. Embody lists four partner pharmacies by name and street address in its site footer, while Fifty 410 describes its pharmacies only as independent 503A compounding pharmacies.

Zevay says prescriptions may be filled by your pharmacy of choice or through its two named partners, Southend Pharmacy and Boothwyn Pharmacy. FancyMeds’ terms name Red Rock Pharmacy and Curexa, but new customers cannot choose between them: the site assigns a pharmacy that ships to your state, so the name on your label is the one to look up. VoyoCare names three partners on its contact page: EPIQ Scripts, Foothills Pharmacy and Emerald Compounding Pharmacy. RxSpan MD names four 503A partners: Belmar, Strive, Epiq Scripts and Casa Pharma. Belle Health names BPI Labs, Hillstone Pharmacy and The Pharmacy Hub.

The terms are often where the name finally appears. ElliotMeds’ terms say every prescription it takes is filled by RxRoute, a licensed compounding pharmacy in Tomball, Texas. Stone Health’s terms give street addresses for four partner pharmacies, among them RedRock Pharmacy in St. George, Utah, and Health Warehouse in Florence, Kentucky, though its site never names the medical group whose clinicians prescribe.

Search the state board of pharmacy license database

This is the check FDA itself tells consumers to run, and the agency maintains a page linking every state board's license lookup so you do not have to find yours.[2] Its instruction is unusually blunt for a federal safety page. If your online pharmacy is not listed, you should not use that pharmacy. FDA then asks you to confirm three more things about a listed pharmacy: that it requires a doctor's prescription, that it gives a physical US address and telephone number, and that a licensed pharmacist is available to answer questions.[2]

Two states can matter, not one. FDA's warning signs list treats a pharmacy that is “not licensed in the United States and by your state board of pharmacy” as unsafe.[1] A pharmacy in another state that ships to you is generally answerable to your board as well as its own, so search both. Boards also post disciplinary actions. Read those in full, not just the headline.

State boards carry more of this weight than people expect. FDA's own answer to who inspects compounders is that state boards have primary responsibility for the day-to-day oversight of state-licensed pharmacies not registered as outsourcing facilities; FDA conducts surveillance and for-cause inspections of those pharmacies but is not the routine inspector.[3] For a 503A pharmacy, the state board is the register that counts.

If the seller claims 503B, read FDA's register

FDA publishes every facility registered under section 503B, updated weekly, and the table carries more than names. Each row gives the initial registration date, the most recent registration date, the date of the last FDA inspection, whether a Form FDA 483 was issued, whether a recall was conducted, and what action followed the inspection.[4] When we pulled it on August 14, 2026 it held 98 facilities, and 40 of them carried the words “Not yet inspected”. Our analysis of the 503B register goes through it in detail and shows why that headline number misleads.

Registering is not approval, and FDA has said so in writing. In the Maximus letter FDA states that the FD&C Act does not establish an “FDA-approved” or “FDA-licensed” designation for pharmacies or outsourcing facilities, and that electing to register as a 503B facility “does not constitute FDA approval or licensure of the facility or its compounded drug products”.[5] Neither 503A nor 503B compounders undergo premarket review. FDA does not verify the safety, effectiveness or quality of a compounded drug before it is marketed.[3]

One more limit on that table, stated by FDA on the page itself: it does not include state board of pharmacy actions. To find out whether a registered facility has been the subject of a state enforcement action you have to go to the board in the state where the facility sits.[4] A clean row on FDA's table can leave out a state action.

Match on name and city, never on name alone

The lookup itself is where verification most easily goes wrong. Our own register holds 68 pharmacies and seven of them appear on FDA's 503B list, but one of those seven is “Empower Pharmacy” on our side and “Empower Pharma” on FDA's. That pairing is only trustworthy because both are in Houston, Texas. We require a name and a city and a state before we call it a match, and when two candidates sit in one city we record no match at all.

Run your own search the same way. A resemblance between two company names is a reason to keep looking, not a result.

Absence from FDA's 503B register means nothing about a 503A pharmacy. State-licensed compounding pharmacies are licensed by state boards and never appear on that list. Most of our 68 are correctly absent from it. If you search a pharmacy there and find nothing, you have learned that it is not an outsourcing facility, and you have learned nothing else.

Read accreditation for what it certifies

Two seals show up constantly on GLP-1 checkout pages. Both are real, both are voluntary, and neither is a government authorization.

NABP's Digital Pharmacy Accreditation runs for three years and is open to a licensed US pharmacy with a website offering at least one interactive pharmacy service. It requires current active state licenses, a pharmacist in responsible charge, a record of dispensing, and an active .pharmacy domain obtained through NABP's Healthcare Merchant Accreditation.[6] What it verifies is that a licensed pharmacy is running a legitimate dispensing operation online. It says nothing about any specific product on the site, and a compounded GLP-1 is not approved merely because the pharmacy that made it is accredited.

PCAB accreditation, run by the Accreditation Commission for Health Care, is aimed at compounding specifically: it verifies compliance with USP General Chapters <795>, <797> and <800>, the standards governing nonsterile compounding, sterile compounding and hazardous drug handling.[7] It is a meaningful credential but an optional one, so its absence is not a violation; 14 of the 68 pharmacies in our register carry it.

Treat any seal as a claim until you find it in the accrediting body's own directory. Both organizations publish searchable lists of who currently holds their accreditation, which is the only place the badge on a seller's footer can be confirmed. Some of the credentials in our own register are self-reported by the seller and we label them that way, because repeating a badge does not confirm it.

Sellers repeat these seals on behalf of their pharmacies. Gentle Health says Premium Compounding Pharmacy, one of the three it names, is accredited by PCAB. SkinnyVIP describes Hallandale Pharmacy as PCAB-accredited. Nimbus Healthcare says its GLP-1s are made in its own NABP-accredited pharmacy in Austin.

LegitScript is the third badge you will meet, and it usually sits on the seller’s own footer rather than the pharmacy’s. Read the wording and whom it is attached to. Prime Health and Trillium Meds list LegitScript certification for themselves, and LifeRx.md claims it too. FMmeds, Somi Health and Roboclinic say “LegitScript Verified,” as does Welling Health, which was not yet open for prescribing when we last read its site. MediRX shows a LegitScript badge on its homepage. MD Trim Clinic is a different case: it says the pharmacies that dispense for it are LegitScript-certified, which is a claim about the pharmacy, not about the clinic. Whichever form the claim takes, confirm it with LegitScript before you count it.

Check the warning letters

FDA publishes warning letters in a searchable database, and the GLP-1 market appears in it heavily. We mirror the ones that name GLP-1 drugs in our warning letter register, which held 157 letters dated from October 2, 2023 to September 18, 2026 at our last count, on September 30, 2026. The largest groups are unlawful internet sales of unapproved and misbranded drugs, and false or misleading marketing claims.[8]

Two cautions when you search it yourself. Match on the company and its address, not on a name that looks close, for the same reason the register lookup needs a city. And read what the letter alleges. A letter is a disclosure, not a disqualification. Several concern website wording rather than what came out of the clean room, and a company that answered a letter and fixed the claim is in a different position from one that did not.

A seal and a letter can sit on the same company. Fitish lists itself as LegitScript Verified and also received an FDA warning letter, which found its claims about compounded semaglutide and tirzepatide false or misleading, including labels bearing the Fitish name that suggested Fitish made the drugs. Neither fact cancels the other, which is why both checks are on this list.

Categories that do not exist

Learn to spot one class of marketing line on sight: it invokes an FDA category that has never existed. FDA made the point directly in the Maximus letter. Representing a compounding pharmacy or outsourcing facility as FDA-approved or FDA-licensed is false and misleading, because those terms imply a formal authorization FDA does not grant to such entities or their compounded products.[5]

  • “FDA-approved compounded semaglutide”. Compounded drugs are not FDA-approved, by definition, and the phrase describes nothing.[3]
  • “FDA-approved pharmacy” or “FDA-licensed pharmacy”. The FD&C Act establishes no such designation.[5]
  • “FDA-monitored” or “FDA-inspected facility” as a quality claim. An inspection date is a fact you can look up, and in our November 6, 2026 pull 43 of the 100 registered facilities had never had one.[4]
  • “Tested in FDA-approved labs”. FDA does not approve testing laboratories in the sense this sentence needs. Ask instead for the certificate of analysis and who issued it.
  • “FDA-registered” used to mean approved. Registration is an administrative filing, and FDA says explicitly that it is not approval or licensure of the facility or its products.[5]

FDA’s June 2026 letter to Clover Meds cited it for calling its source pharmacies “FDA-licensed”. Its site now lists Casa Pharma RX and Hallandale Pharmacy as licensed sterile 503A compounding pharmacies, each with a street address. SkinnyRx’s February 2026 warning letter cited website labels that showed the SkinnyRx name, implying it compounds drugs it does not make, and its site still does not name its compounding pharmacy.

Red flags that end the check early

FDA's own warning signs for an online pharmacy are short: it does not require a doctor's prescription, it is not licensed in the US and by your state board, it has no licensed pharmacist to answer questions, the medicine arrives looking different or in damaged or foreign-language packaging with no expiration date, the discounts are too good to be true, or it charges you for things you never ordered.[1] From tracing this market we would add four more.

  • No pharmacy is named anywhere, including in the terms of service and on the vial. There is no license to look up and no one to complain to.
  • Payment is taken before any clinician is involved. A questionnaire reviewed by a prescriber is lawful in most states and can be legitimate; a checkout that charges the card first has put the consult after the sale.
  • A label reading “not for human consumption”, or “research use only”. That is the seller's legal position in writing, not a grade of product, and we take it apart in what “research use only” really means.
  • No prescription required at all. FDA's guidance for buying medicine online reduces to using a state-licensed pharmacy and holding a real prescription; the rest of the argument is downstream of that.[9] Every GLP-1 drug, pen or pill, is prescription-only in the US.

The six checks, in order

  1. Name the dispensing pharmacy. Check the terms of service, the privacy policy, the order confirmation and the vial. If no document names one, stop here.
  2. Search your state board's license database, and the pharmacy's home state board. Not listed means do not use it.[2]
  3. If the seller claims 503B, find the facility on FDA's register by name and city and state, and read the last-inspection column rather than the fact of registration.[4]
  4. Confirm any accreditation seal in the accrediting body's own directory, and read what that accreditation covers.[6][7]
  5. Search FDA's warning letters for the operating entity and the pharmacy, matching on company and address.[8]
  6. Read the claims for categories that do not exist, then read the billing terms. A month is sometimes four weeks, and a headline is often a first-month rate; our price tracker carries a verified date next to every figure.
What none of this proves is what is in the vial. These registers establish who is licensed, who is registered, who has been inspected and who has been written to. No public register tells a consumer the actual contents or concentration of a compounded preparation, and we cannot verify that for you either. That is the gap what is actually in a compounded GLP-1 vial is about.

Frequently Asked Questions

Not by itself. It is a signal rather than a violation. A seller is entitled to keep supplier relationships private, and you are entitled to decline to inject something whose maker you are not allowed to know. FDA has asked at least one telehealth seller to identify the entities producing the compounded products on its website, which tells you the information is not always volunteered.
Read the registration dates before deciding. Most facilities carrying "Not yet inspected" registered recently, and FDA inspects on a risk-based schedule rather than a calendar. A facility registered years ago and never inspected is a different fact from one registered a few months ago, and the register gives you both dates.
Almost certainly not. State-licensed 503A pharmacies never appear on that list. It is the wrong register for them, and their license lives with the state board instead. Absence from a federal list you were never on is not evidence of anything.
Accreditation is real work and it is voluntary, so holding it tells you something and lacking it tells you very little. What it does not do is review any individual product. A compounded GLP-1 from an accredited pharmacy has still not been evaluated by FDA for safety, effectiveness or quality.
Not on the strength of a letter alone, and not without your prescriber. Read what the letter alleges first, since many concern website claims rather than the preparation itself. Bring it to the clinician managing your dose, who is the person who can weigh a change against what stopping would do.

References

  1. 1.U.S. Food and Drug Administration Considering an Online Pharmacy? BeSafeRx: Your Source for Online Pharmacy Information. 2020. https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/considering-online-pharmacy
  2. 2.U.S. Food and Drug Administration Locate a State-Licensed Online Pharmacy BeSafeRx: Your Source for Online Pharmacy Information. 2024. https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy
  3. 3.U.S. Food and Drug Administration Compounding and the FDA: Questions and Answers FDA Human Drug Compounding. 2025. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
  4. 4.U.S. Food and Drug Administration Registered Outsourcing Facilities FDA Human Drug Compounding. 2026. https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
  5. 5.U.S. Food and Drug Administration Warning Letter to Maximus Health, Inc. dba Maximus (MARCS-CMS 730095), June 8, 2026 FDA Warning Letters. 2026. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/maximus-health-inc-dba-maximus-730095-06082026
  6. 6.National Association of Boards of Pharmacy Digital Pharmacy Accreditation NABP Accreditation Programs. 2026. https://nabp.pharmacy/programs/accreditations/digital-pharmacy/
  7. 7.Accreditation Commission for Health Care PCAB Accreditation for Compounding Pharmacies ACHC Programs. 2026. https://www.achc.org/pcab/
  8. 8.U.S. Food and Drug Administration Warning Letters FDA Compliance Actions and Activities. 2026. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters
  9. 9.U.S. Food and Drug Administration FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss FDA Drug Alerts and Statements. 2026. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss

Is Compounded Tirzepatide Safe? What FDA Has Actually Reported

FDA has never reviewed compounded tirzepatide for safety, effectiveness or quality. That is a fact about regulatory review, not a finding of harm. This covers what the agency has reported, what separates a 503A pharmacy from a 503B facility, and what nobody can tell you.

11 min read

Compounded Semaglutide and Tirzepatide Are Ending: What to Do Next

The federal permission that made large-scale GLP-1 compounding lawful has closed. Three routes remain, one to avoid, and the questions to ask before you move.

6 min read

What Is in a Compounded GLP-1 Vial: How to Read the Label

An approved pen delivers a dose; a compounded vial delivers a concentration, and someone has to convert one into the other. This is how to read the label, not how to dose.

9 min read

Compounded Tirzepatide Side Effects: The Drug, and the Vial

Most compounded tirzepatide side effects are tirzepatide side effects, documented in the approved product's label and trials. A smaller set comes from the preparation: a pharmacy-set concentration, added ingredients, and an adverse-event pathway that may never count your report.

10 min read

Which GLP-1s Can Be Compounded? The FDA Shortage and Bulks-List Rules

Both federal routes for compounding semaglutide and tirzepatide depended on FDA shortage status. Both shortages are closed, and FDA has proposed shutting the remaining route.

7 min read

Compounded Semaglutide: Is a Prescription Required?

Yes, but 503A and 503B do not carry the same requirement, and the gap between them is where the no-prescription pitches live. What each route actually asks for.

5 min read

Where to get tirzepatide online, safely: sellers our editors have checked

These are telehealth sellers our editors have checked. For each one we hold a price, the form the drug comes in, and the states it reaches.

No insurance needed · vetted by our editors

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

8.7

Eden

Coverage in all 50 states, which most sellers will not confirm

8.2

bmiMD

Starting below a standard dose, with microdose tiers

6.3

WellMedRx

Comparing compounded and brand GLP-1 plans with a published state list

About this analysis

GLP Watchdog publishes independently. Each seller in our dataset is checked against that seller's own website, and the dataset is updated continuously. Read our full methodology →